PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
14 Sep 2016
PDL1 and other biomarkers for selecting patients for immune checkpoint therapies
State of the art imaging and lung cancer management
Future smart surgical approaches for brain metastases
Future directions in radiation medicine
How to avoid false positives in lung cancer
Current state of the art radiotherapy in lung cancer
Maintenance in NSCLC
Recent advances and emerging therapies in lung cancer
Editor's Choice for August 2016
Breaking down barriers to cancer communication worldwide
Drug repurposing in review
Bring patient voices into research